Virtual meeting
Via Zoom
Description
As part of the twice-monthly SUD Care Continuum ECHO® series, Julia Calandra, PharmD, BCACP, will develop interdisciplinary models of low-barrier hepatitis C care that improve coordination between addiction treatment, medical, and harm reduction services and describe principles of low-barrier, person-centered hepatitis C care and their role in reducing disparities among people who use substances. She will also apply practical strategies for integrating hepatitis C screening and treatment into addiction medicine and harm reduction settings, including models such as group care. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
The Substance Use Disorder Care Continuum ECHO® (SUD Care Continuum ECHO®) series offers training and support in addiction treatment, with a focus on supporting front line addiction treatment workforce. This includes health providers in Acute Treatment Services (ATS), Crisis Stabilization Services (CSS), Transitional Support Services (TSS), Opioid Treatment Programs (OTP), long-term residential program, sober and recovery homes, primary care, and psychiatry. This free, case-based tele-mentoring program is designed to increase the capacity of health care providers to implement high-quality and evidence-based addiction treatment.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Julia Calandra, PharmD, BCACP
Julia Calandra graduated from the University of Pittsburgh School of Pharmacy in 2021. After graduation, she then pursued two years of pharmacy residency training in Ambulatory Care with Mountain Area Health Education Center in Asheville, North Carolina. Her clinical interests include working with patients with substance use disorders, who are gender diverse seeking gender-affirming care, and public health. She is a firm believer in harm reduction, compassionate care, and ethical medical care to historically marginalized populations.
Objectives
Following this training, participants will have the knowledge to:
1. Develop interdisciplinary models of low-barrier hepatitis C care that improve coordination between addiction treatment, medical, and harm reduction services.
2. Describe principles of low-barrier, person-centered hepatitis C care and their role in reducing disparities among people who use substances.
3. Apply practical strategies for integrating hepatitis C screening and treatment into addiction medicine and harm reduction settings, including models such as group care.
Sponsored by
Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Accreditation information
Please read the Accreditation Information section of the training registration page for accreditation details and to learn about the requirements for receiving credit or a certificate of completion.
